USE OF SEROTONIN REUPTAKE INHIBITOR FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS.

摘要

The present invention refers to imidazoline indol such as 3-[2-(4,5-dihydro-1H-imidazol-2-yl)ethyl]-5-fluoro-1H-indol and the pharmaceutically acceptable salts thereof, which blocks the extracellular reuptake of the serotonin monoaminergic neurotrasnsmitter (5-hidroxytriptamine or 5-HT) in the presynaptic neuron, thus increasing the effective concentration of this neurotransmitter so as to be linked to the postsynaptic receptors 5-HT. The compounds of the invention are applied in neuro-psychiatric diseases such as depression.